GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Diplomat Pharmacy Inc (NYSE:DPLO) » Definitions » Piotroski F-Score

Diplomat Pharmacy (Diplomat Pharmacy) Piotroski F-Score : 0 (As of Apr. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Diplomat Pharmacy Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Diplomat Pharmacy has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Diplomat Pharmacy's Piotroski F-Score or its related term are showing as below:


Diplomat Pharmacy Piotroski F-Score Historical Data

The historical data trend for Diplomat Pharmacy's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diplomat Pharmacy Piotroski F-Score Chart

Diplomat Pharmacy Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Piotroski F-Score
Get a 7-Day Free Trial 6.00 5.00 5.00 4.00 5.00

Diplomat Pharmacy Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 5.00 3.00 3.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep19) TTM:Last Year (Sep18) TTM:
Net Income was -298.025 + -14.301 + -159.462 + -177.28 = $-649 Mil.
Cash Flow from Operations was 1.835 + 23.652 + 43.098 + 41.295 = $110 Mil.
Revenue was 1360.628 + 1256.808 + 1287.624 + 1301.197 = $5,206 Mil.
Gross Profit was 93.856 + 79.22 + 72.727 + 63.385 = $309 Mil.
Average Total Assets from the begining of this year (Sep18)
to the end of this year (Sep19) was
(1800.661 + 1476.359 + 1447.068 + 1315.11 + 1162.603) / 5 = $1440.3602 Mil.
Total Assets at the begining of this year (Sep18) was $1,801 Mil.
Long-Term Debt & Capital Lease Obligation was $24 Mil.
Total Current Assets was $542 Mil.
Total Current Liabilities was $992 Mil.
Net Income was 6.536 + -0.45 + -3.964 + 0.169 = $2 Mil.

Revenue was 1155.069 + 1342.484 + 1416.078 + 1373.334 = $5,287 Mil.
Gross Profit was 72.579 + 90.378 + 98.416 + 93.358 = $355 Mil.
Average Total Assets from the begining of last year (Sep17)
to the end of last year (Sep18) was
(1154.049 + 1940.423 + 1831.909 + 1817.87 + 1800.661) / 5 = $1708.9824 Mil.
Total Assets at the begining of last year (Sep17) was $1,154 Mil.
Long-Term Debt & Capital Lease Obligation was $441 Mil.
Total Current Assets was $550 Mil.
Total Current Liabilities was $578 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Diplomat Pharmacy's current Net Income (TTM) was -649. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Diplomat Pharmacy's current Cash Flow from Operations (TTM) was 110. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep18)
=-649.068/1800.661
=-0.36046096

ROA (Last Year)=Net Income/Total Assets (Sep17)
=2.291/1154.049
=0.00198518

Diplomat Pharmacy's return on assets of this year was -0.36046096. Diplomat Pharmacy's return on assets of last year was 0.00198518. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Diplomat Pharmacy's current Net Income (TTM) was -649. Diplomat Pharmacy's current Cash Flow from Operations (TTM) was 110. ==> 110 > -649 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep19)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep18 to Sep19
=23.538/1440.3602
=0.01634175

Gearing (Last Year: Sep18)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep17 to Sep18
=440.552/1708.9824
=0.25778615

Diplomat Pharmacy's gearing of this year was 0.01634175. Diplomat Pharmacy's gearing of last year was 0.25778615. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep19)=Total Current Assets/Total Current Liabilities
=542.177/991.542
=0.54680185

Current Ratio (Last Year: Sep18)=Total Current Assets/Total Current Liabilities
=549.726/578.485
=0.95028566

Diplomat Pharmacy's current ratio of this year was 0.54680185. Diplomat Pharmacy's current ratio of last year was 0.95028566. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Diplomat Pharmacy's number of shares in issue this year was 75.509. Diplomat Pharmacy's number of shares in issue last year was 74.742. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=309.188/5206.257
=0.05938777

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=354.731/5286.965
=0.06709539

Diplomat Pharmacy's gross margin of this year was 0.05938777. Diplomat Pharmacy's gross margin of last year was 0.06709539. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep18)
=5206.257/1800.661
=2.89130325

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep17)
=5286.965/1154.049
=4.58123095

Diplomat Pharmacy's asset turnover of this year was 2.89130325. Diplomat Pharmacy's asset turnover of last year was 4.58123095. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Diplomat Pharmacy has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Diplomat Pharmacy  (NYSE:DPLO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Diplomat Pharmacy Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Diplomat Pharmacy's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Diplomat Pharmacy (Diplomat Pharmacy) Business Description

Traded in Other Exchanges
N/A
Address
4100 South Saginaw Street, Flint, MI, USA, 48507
Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.
Executives
Brian T Griffin director, officer: Chairman and CEO
David C Dreyer director C/O SICOR INC, 19 HUGHES, IRVINE CA 92618-1902
Shawn Tomasello director C/O PHARMACYCLICS, INC, 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Jeffrey G Park director C/O DIPLOMAT PHARMACY, INC., 4100 S. SAGINAW ST., FLINT MI 48507
Sean Whelan director, officer: Chief Financial Officer C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Jeffrey M Rowe director, officer: EVP of Operations C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018

Diplomat Pharmacy (Diplomat Pharmacy) Headlines

From GuruFocus

Diplomat Using SMRxT Technology to Enhance Patient Care

By PRNewswire PRNewswire 04-26-2019